← Back to Search

Predictors of Hyperandrogenism for Polycystic Ovary Syndrome (SHK001 Trial)

Phase < 1

Recruiting

Led By Su H Kim, MD

Research Sponsored by University of Virginia

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Willingness to strictly avoid pregnancy (using non-hormonal methods) during the time of the study

Subject is considered to have PCOS if she has current or verifiable history of: clinical and/or biochemical evidence of hyperandrogenism plus oligomenorrhea or irregular menstruation

Must not have

Persistent liver abnormalities

Biochemical evidence for perimenopause as defined by an anti-Mullerian hormone <0.5 ng/mL or cycle day 3 FSH > 9 IU/L (with concomitant estradiol level >80 pg/mL)

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 30 minutes and 1 hour after acth

Awards & highlights

Summary

This trial is studying how well four established predictors of hyperandrogenism work in older and younger women with PCOS.

Who is the study for?

This trial is for women aged 20-30 and 40-49 with PCOS, showing signs of excess male hormones and irregular periods. They must not be at risk of pregnancy, willing to follow the study plan, and have no history of severe health issues like heart disease or diabetes. Women close to menopause or with certain hormonal disorders are excluded.

What is being tested?

The study aims to understand how different factors contribute to high male hormone levels in younger vs. older women with PCOS by testing their responses to rhCG (a fertility drug) and ACTH (a hormone that stimulates adrenal glands).

What are the potential side effects?

Potential side effects from rhCG may include abdominal pain, swelling, shortness of breath, diarrhea, nausea or vomiting. ACTH can cause allergic reactions, increased blood pressure, changes in mood or behavior, electrolyte imbalances and muscle weakness.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am committed to preventing pregnancy using non-hormonal methods during the study.

Select...

I have PCOS with signs of high male hormones and irregular periods.

Select...

I am a woman with PCOS and I am either 20-30 or 40-49 years old.

Select...

I am willing and able to follow the study's schedule and procedures.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I have ongoing liver problems.

Select...

My hormone levels indicate I am in perimenopause.

Select...

I have had my uterus and/or both ovaries removed.

Select...

I have a history of heart or brain blood flow problems.

Select...

I have a history of heart failure.

Select...

A close family member has a history of blood clotting disorders.

Select...

I have had Cushing's syndrome or adrenal insufficiency.

Select...

I have a significant history of lung problems.

Select...

I have had a blood clot in my veins or lungs before.

Select...

I have diabetes with high blood sugar or A1c levels.

Select...

I have a history of congenital adrenal hyperplasia or my 17-OHP levels are above 200 ng/dL.

Select...

My ovaries are enlarged, as confirmed by an ultrasound.

Select...

I have a history of breast, ovarian, or endometrial cancer.

Select...

I have a history of blood clotting disorders.

Select...

I am postmenopausal, with no periods for over a year and high FSH levels.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 30 mininutes and 1 hour after adrenocorticotropic hormone (acth), 24 hours after recombinant human chorionic gonadotropin (rhcg).

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 30 mininutes and 1 hour after adrenocorticotropic hormone (acth), 24 hours after recombinant human chorionic gonadotropin (rhcg).

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 30 mininutes and 1 hour after adrenocorticotropic hormone (acth), 24 hours after recombinant human chorionic gonadotropin (rhcg). for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Corticotropin

Change in calculated free testosterone concentrations

Change in ovarian 17-hydroxyprogesterone to r-hCG

+2 more

Secondary study objectives

Change in DHEA to ACTH

Change in androstenedione to ACTH

Change in androstenedione to r-hCG

+3 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: ACTH (Cosyntropin), rhCG (Ovidrel)Experimental Treatment2 Interventions

ACTH (Cosyntropin) administered 250 mcg IV; rhCG (Ovidrel) administered 250 mcg IV

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

ACTH

2013

Completed Phase 4

~150

0 / 19Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of VirginiaLead Sponsor

771 Previous Clinical Trials

1,284,153 Total Patients Enrolled

26 Trials studying Polycystic Ovary Syndrome

1,060 Patients Enrolled for Polycystic Ovary Syndrome

Su H Kim, MDPrincipal InvestigatorUniversity of Virginia

1 Previous Clinical Trials

88 Total Patients Enrolled

1 Trials studying Polycystic Ovary Syndrome

88 Patients Enrolled for Polycystic Ovary Syndrome

Chris McCartney, MDPrincipal InvestigatorUniversity of Virginia

2 Previous Clinical Trials

148 Total Patients Enrolled

2 Trials studying Polycystic Ovary Syndrome

148 Patients Enrolled for Polycystic Ovary Syndrome

Media Library

rhCG Clinical Trial Eligibility Overview. Trial Name: NCT03905603 — Phase < 1

Polycystic Ovary Syndrome Research Study Groups: ACTH (Cosyntropin), rhCG (Ovidrel)

Polycystic Ovary Syndrome Clinical Trial 2023: rhCG Highlights & Side Effects. Trial Name: NCT03905603 — Phase < 1

rhCG 2023 Treatment Timeline for Medical Study. Trial Name: NCT03905603 — Phase < 1

~34 spots leftby Apr 2026

Unbiased ResultsWe believe in providing patients with all the options.

Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.

Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.